AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIH

Restructuring NIAID’s HIV/AIDS Clinical Trials Networks

Future Directions for NIAID HIV Research

Over the next several weeks, the National Institute of Allergy and Infectious Diseases (NIAID) will post a series of entries here on AIDS.gov related to planning for the future of NIAID’s HIV/AIDS clinical trial networks. The awards supporting the six current HIV/AIDS networks are set to expire in 2013 and 2014. Building on the success…

Pursuing a “Cure” for HIV/AIDS – Two Distinct Approaches

Dr. Carl Dieffenbach, PhD

Contrary to what you may have heard or read on the Internet, there is currently no cure for HIV/AIDS. While some say that there may never be a cure, I believe there is reason for hope. That’s because some of our best scientists are working on two distinct approaches to finding a cure for HIV/AIDS,…

Drug Regimen with Short Pauses Controls HIV and Could Lower Costs, Toxicity

blog.aids.gov

Antiretroviral drugs for HIV infection usually are taken daily, and interrupting treatment for long periods of time has proven detrimental. However, a clinical trial in Uganda has found that pausing antiretroviral therapy (ART) for just two days every week is at least as effective as taking ART continuously over a 72-week period. In addition, the…

Putting TLC+ to the Test

Listen:

Javascript and flash are required to play this audio file.

Download MP3
Dr. Carl Dieffenbach, PhD

If we routinely test everyone for HIV and treat those who are infected, could we bring an end to the HIV/AIDS epidemic? The test and treat concept, modeled on data from South Africa by scientists at the World Health Organization, is a provocative HIV prevention strategy. According to mathematical modeling, a successfully implemented test and…

Goals of a Social Networking Symposium for NIH Staff

STEP: Staff Training in Extramural Programs

AIDS.gov note: Earlier this month, AIDS.gov presented an overview on using new and social media to approximately 400 Federal staff from the National Institutes of Health. (The session was offered both live and via webcast.) We applaud NIH’s commitment to providing ongoing educational opportunities for their staff. Megan Morena, Janice Nall, Miguel Gomez To learn…

Dr. Anthony S. Fauci’s Statement for National Gay Men’s HIV/AIDS Awareness Day

Dr. Anthony Fauci

Last Sunday, September 27, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease, National Institutes of Health, released a statement to acknowledge National Gay Men’s HIV/AIDS Awareness Day and research issues impacting gay men. To read the entire statement, visit the NIAID website. Anthony S. Fauci, M.D., Director of NIAID Gay…